Logo image of BYON

BEYOND INC (BYON) Stock Fundamental Analysis

NYSE:BYON - New York Stock Exchange, Inc. - US6903701018 - Common Stock - Currency: USD

8.965  -0.26 (-2.77%)

Fundamental Rating

1

Taking everything into account, BYON scores 1 out of 10 in our fundamental rating. BYON was compared to 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of BYON have multiple concerns. BYON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BYON has reported negative net income.
In the past year BYON has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: BYON reported negative net income in multiple years.
In multiple years BYON reported negative operating cash flow during the last 5 years.
BYON Yearly Net Income VS EBIT VS OCF VS FCFBYON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

BYON's Return On Assets of -79.03% is on the low side compared to the rest of the industry. BYON is outperformed by 94.87% of its industry peers.
The Return On Equity of BYON (-172.55%) is worse than 82.05% of its industry peers.
Industry RankSector Rank
ROA -79.03%
ROE -172.55%
ROIC N/A
ROA(3y)-6.55%
ROA(5y)-8.47%
ROE(3y)-14.74%
ROE(5y)-27.05%
ROIC(3y)N/A
ROIC(5y)N/A
BYON Yearly ROA, ROE, ROICBYON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

With a Gross Margin value of 19.00%, BYON is not doing good in the industry: 82.05% of the companies in the same industry are doing better.
BYON's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BYON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5Y0.7%
BYON Yearly Profit, Operating, Gross MarginsBYON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

BYON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYON has been increased compared to 1 year ago.
BYON has more shares outstanding than it did 5 years ago.
BYON has a worse debt/assets ratio than last year.
BYON Yearly Shares OutstandingBYON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BYON Yearly Total Debt VS Total AssetsBYON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

BYON has an Altman-Z score of 0.73. This is a bad value and indicates that BYON is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.73, BYON is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
BYON has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, BYON is doing good in the industry, outperforming 64.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACCN/A
WACC9.96%
BYON Yearly LT Debt VS Equity VS FCFBYON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.97 indicates that BYON may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.97, BYON is doing worse than 77.78% of the companies in the same industry.
BYON has a Quick Ratio of 0.97. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
BYON has a better Quick ratio (0.91) than 71.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.91
BYON Yearly Current Assets VS Current LiabilitesBYON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BYON have decreased strongly by -562.34% in the last year.
BYON shows a decrease in Revenue. In the last year, the revenue decreased by -6.66%.
BYON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.04% yearly.
EPS 1Y (TTM)-562.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.03%
Revenue 1Y (TTM)-6.66%
Revenue growth 3Y-14.46%
Revenue growth 5Y-3.04%
Sales Q2Q%-16.58%

3.2 Future

Based on estimates for the next years, BYON will show a very strong growth in Earnings Per Share. The EPS will grow by 20.23% on average per year.
BYON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.03% yearly.
EPS Next Y-132.19%
EPS Next 2Y4.35%
EPS Next 3Y19.49%
EPS Next 5Y20.23%
Revenue Next Year-6.5%
Revenue Next 2Y-1.13%
Revenue Next 3Y3.38%
Revenue Next 5Y11.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BYON Yearly Revenue VS EstimatesBYON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
BYON Yearly EPS VS EstimatesBYON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BYON. In the last year negative earnings were reported.
Also next year BYON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYON Price Earnings VS Forward Price EarningsBYON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYON Per share dataBYON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

BYON's earnings are expected to grow with 19.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.35%
EPS Next 3Y19.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BYON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND INC

NYSE:BYON (2/6/2025, 12:59:09 PM)

8.965

-0.26 (-2.77%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-24 2024-10-24/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst Owners67.4%
Inst Owner ChangeN/A
Ins Owners1.3%
Ins Owner Change30.33%
Market Cap412.84M
Analysts72.94
Price Target15.96 (78.03%)
Short Float %19.41%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.49%
Min EPS beat(2)-81.15%
Max EPS beat(2)-15.83%
EPS beat(4)0
Avg EPS beat(4)-60.49%
Min EPS beat(4)-81.63%
Max EPS beat(4)-15.83%
EPS beat(8)3
Avg EPS beat(8)-50.83%
EPS beat(12)6
Avg EPS beat(12)-33.8%
EPS beat(16)10
Avg EPS beat(16)30.38%
Revenue beat(2)1
Avg Revenue beat(2)-5.66%
Min Revenue beat(2)-13.51%
Max Revenue beat(2)2.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-13.51%
Max Revenue beat(4)8.93%
Revenue beat(8)4
Avg Revenue beat(8)-2.46%
Revenue beat(12)5
Avg Revenue beat(12)2.84%
Revenue beat(16)7
Avg Revenue beat(16)2.73%
PT rev (1m)-0.9%
PT rev (3m)-24.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.01%
EPS NY rev (1m)-4.05%
EPS NY rev (3m)-5.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 2.1
P/tB 2.59
EV/EBITDA N/A
EPS(TTM)-5.1
EYN/A
EPS(NY)-1.78
Fwd EYN/A
FCF(TTM)-4.35
FCFYN/A
OCF(TTM)-3.92
OCFYN/A
SpS32.06
BVpS4.26
TBVpS3.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.03%
ROE -172.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19%
FCFM N/A
ROA(3y)-6.55%
ROA(5y)-8.47%
ROE(3y)-14.74%
ROE(5y)-27.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5Y0.7%
F-Score2
Asset Turnover3.45
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 115.37%
Cap/Sales 1.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.91
Altman-Z 0.73
F-Score2
WACC9.96%
ROIC/WACCN/A
Cap/Depr(3y)131.23%
Cap/Depr(5y)105.16%
Cap/Sales(3y)1.38%
Cap/Sales(5y)1.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-562.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.03%
EPS Next Y-132.19%
EPS Next 2Y4.35%
EPS Next 3Y19.49%
EPS Next 5Y20.23%
Revenue 1Y (TTM)-6.66%
Revenue growth 3Y-14.46%
Revenue growth 5Y-3.04%
Sales Q2Q%-16.58%
Revenue Next Year-6.5%
Revenue Next 2Y-1.13%
Revenue Next 3Y3.38%
Revenue Next 5Y11.03%
EBIT growth 1Y-278.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-47.84%
EBIT Next 3Y29.45%
EBIT Next 5Y22.53%
FCF growth 1Y-10803.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1263.8%
OCF growth 3YN/A
OCF growth 5YN/A